A First-in-class highly selective complement 5a receptor antagonist—avacopan

doi:10.3969/j.issn.1672-3384.2024.11.006

Shanshan ZHANG, Zinan ZHAO, Wenfeng XU, Fei ZHAO, Tianqi ZHANG, Pengfei JIN

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (11) : 31-36.

PDF(459 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (11) : 31-36. DOI: 10.3969/j.issn.1672-3384.2024.11.006

Comment of New Drug

A First-in-class highly selective complement 5a receptor antagonist—avacopan

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(11): 31-36 https://doi.org/10.3969/j.issn.1672-3384.2024.11.006

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(459 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-10-30	2024-11-20
Issue Date
2025-01-20

Please choose a citation manager

Content to export